Literature DB >> 31187472

Author's Reply to Trechot: "Comment on Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?"

Didier Concordet1, Peggy Gandia1, Jean-Louis Montastruc2, Alain Bousquet-Mélou1, Peter Lees3, Aude A Ferran1, Pierre-Louis Toutain4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31187472     DOI： 10.1007/s40262-019-00787-9

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  2 in total

1.  Comment on: Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?

Authors:  Philippe Tréchot
Journal:  Clin Pharmacokinet       Date:  2019-07       Impact factor: 6.447

2.  Authors' Reply to Lechat et al.: "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?"

Authors:  Didier Concordet; Peggy Gandia; Jean-Louis Montastruc; Alain Bousquet-Mélou; Peter Lees; Aude A Ferran; Pierre-Louis Toutain
Journal:  Clin Pharmacokinet       Date:  2019-10       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.